Respiratory syncytial virus (RSV) is a common infection in infants and a major cause of bronchiolitis and pneumonia, especially affecting children under 1 year old. To reduce infection risks, Taipei City will launch a new subsidy policy on July 1, offering vaccines or monoclonal antibody injections for pregnant women and high-risk infants to help families build early protection.

Eligible recipients include pregnant women (28 to 36 weeks) from low-income and lower-middle-income households registered in Taipei City, who can receive one free vaccine dose. In addition, infants under 1 year old who qualify for Category 2 child medical subsidies, as well as high-risk children aged 1 to under 2 years old, may receive one dose of long-acting monoclonal antibodies. Appointments can be made at Taipei City Hospital.

Currently, there is no specific antiviral medication for RSV, making prevention essential. Medical guidance indicates that vaccination during pregnancy can provide protection for infants during their first 6 months. Meanwhile, monoclonal antibody injections for infants can reduce the risk of severe illness after infection. Statistics show that most children are infected before age 2, and severe cases may require hospitalization, placing pressure on families.

Appointments can be made in advance through Taipei City Hospital to reduce waiting time. For eligibility or vaccination inquiries, call the epidemic prevention hotline at 02-2375-3782. The dual approach of vaccines and monoclonal antibodies helps lower infection and severe illness risks, offering stronger protection for infants during early growth.